2 - TI Pharma

REFERENCES
1. Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids.
Pharmacol Ther. 2002;96(1):23-43.
2. van Raalte DH, Ouwens DM, Diamant M. Novel insights into glucocorticoid-mediated diabetogenic
effects: towards expansion of therapeutic options? Eur j Clin Invest. 2009;39(2):81-93.
3. Gulliford MC, Charlton j, Latinovic R. Risk of diabetes associated with prescribed glucocorticoids in
a large population. Diabetes Care. 2006;29(12):2728-9.
4. McMahon M, Gerich j, Rizza R. Effects of glucocorticoids on carbohydrate metabolism. Diabetes
Metab Rev. 1988;4(1):17-30.
5. Lambillotte C, Gilon P, Henquin jC. Direct glucocorticoid inhibition of insulin secretion. An in vitro
study of dexamethasone effects in mouse islets. j Clin Invest. 1997;99(3):414-23.
6. Davani B, Portwood N, Bryzgalova G, Reimer MK, Heiden T, Ostenson CG, Okret S, Ahren B, Efendic
S, Khan A. Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic beta-cells
develop diabetes. Diabetes. 2004;53 Suppl 1:S51-9.
7. van Raalte DH, van Genugten RE, Linssen MM, Ouwens DM, Diamant M. Glucagon-like peptide-1
receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell
dysfunction in humans. Diabetes Care. 2011;34(2):412-7.
8. van Raalte DH, Nofrate V, Bunck MC, van Iersel T, Elassaiss Schaap j, Nassander UK, Heine Rj, Mari
A, Dokter WH, Diamant M. Acute and 2-week exposure to prednisolone impair different aspects of
beta-cell function in healthy men. Eur j Endocrinol. 2010;162(4):729-35.
9. Beard jC, Halter jB, Best jD, Pfeifer MA, Porte D, jr. Dexamethasone-induced insulin resistance
enhances B cell responsiveness to glucose level in normal men. Am j Physiol. 1984;247(5 Pt
1):E592-6.
10. Henriksen jE, Alford F, Ward GM, Beck-Nielsen H. Risk and mechanism of dexamethasone-induced
deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.
Diabetologia. 1997;40(12):1439-48.
11. Larsson H, Ahren B. Insulin resistant subjects lack islet adaptation to short-term dexamethasoneinduced
reduction in insulin sensitivity. Diabetologia. 1999;42(8):936-43.
12. Matsumoto K, Yamasaki H, Akazawa S, Sakamaki H, Ishibashi M, Abiru N, Uotani S, Matsuo H,
Yamaguchi Y, Tokuyama K, Nagataki S. High-dose but not low-dose dexamethasone impairs glucose
tolerance by inducing compensatory failure of pancreatic beta-cells in normal men. j Clin Endocrinol
Metab. 1996;81(7):2621-6.
13. Wajngot A, Giacca A, Grill V, Vranic M, Efendic S. The diabetogenic effects of glucocorticoids are more
pronounced in low- than in high-insulin responders. Proc Natl Acad Sci U S A. 1992;89(13):6035-9.
107
5
Chapter 5